THIN® is a prescription-only compounded semaglutide oral spray — built for eligible patients transitioning off injectable GLP-1 therapy.
Prescription-only. Compounded medication. Not FDA-approved. Dispensed only if a licensed provider determines it is medically appropriate.
Research shows many patients regain a significant share of lost weight within a year of stopping a GLP-1 — often cited around 60–70% within 12 months — as appetite signaling returns. Obesity behaves like a chronic, relapsing condition. The maintenance phase matters.
When injections stop, satiety signaling drops and caloric drive returns. Cravings — especially for sugar — often resurface first.
Many patients return close to baseline within 12–18 months of stopping. The hard-won progress can quietly slip away without a plan.
A convenient, needle-free, prescription-only compounded option designed to support appetite control through the maintenance phase — after provider review.
THIN delivers semaglutide as a sublingual spray under the tongue — designed to absorb through the oral mucosa instead of being swallowed and broken down in the stomach.
THIN is a 503A compounded medication prepared for an individual patient pursuant to a valid prescription. It is not FDA-approved and is not a replacement for all injectable GLP-1 therapy. Individual results vary.
Includes your telehealth provider, medication, and shipping. No insurance necessary.
Payment does not guarantee that a prescription will be written or dispensed.
Fill out a quick, free medical history form so your provider can build the right plan for you.
Connect with a licensed physician or nurse practitioner through a simple online conversation.
If appropriate, your compounded medication ships to your door with free shipping.
THIN is prescription-only and requires review by a licensed provider. Please consult a healthcare professional before starting, especially if you have a history of medical conditions or take other medications.
THIN is a 503A compounded semaglutide oral/sublingual spray — prescription-only and patient-specific. It contains semaglutide, the same active ingredient class associated with Ozempic® and Wegovy®, prepared by a licensed compounding pharmacy. THIN is not FDA-approved.
Sublingual delivery is designed to let medication absorb through the tissues under the tongue and inside the mouth into the bloodstream, rather than being swallowed and broken down in the stomach and liver. Exact absorption for any compounded formulation depends on the product and supporting data.
THIN is positioned as a needle-free maintenance and appetite-support option for eligible patients transitioning off or reducing injectable GLP-1s — complementary to the GLP-1 landscape, not a replacement for all injectable therapy. Your provider will advise what's appropriate for you.
Dosing commonly starts at 2 pumps per day under the tongue, or as directed by your prescriber. No refrigeration is required, so it travels easily.
No. One transparent price includes your telehealth provider visit, the medication if prescribed, and free shipping.
No. Your intake information is reviewed independently by a licensed provider, and medication is only prescribed and dispensed if it is medically appropriate. Payment does not guarantee prescribing or dispensing.
Start your THIN evaluation today and see if needle-free, prescription-only GLP-1 maintenance may be right for you.
Start Your THIN Evaluation